Table 2.
Assessment | Optimized Usual Care
|
Treatment
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
N | Min | Max | Mean | S.D. | N | Min | Max | Mean | S.D. | |
PCL | ||||||||||
Baseline | 33 | 31 | 78 | 54.48 | 11.23 | 40 | 25 | 78 | 58.00 | 9.95 |
6-week | 29 | 23 | 71 | 48.52 | 13.97 | 29 | 20 | 114 | 50.72 | 18.76 |
12-week | 25 | 17 | 72 | 47.36 | 17.45 | 30 | 19 | 83 | 43.80 | 18.33 |
18-week | 27 | 17 | 68 | 42.74 | 14.42 | 31 | 18 | 77 | 44.58 | 16.43 |
PHQ-8 | ||||||||||
Baseline | 33 | 4 | 22 | 11.67 | 4.65 | 40 | 3 | 22 | 13.53 | 5.43 |
6-week | 29 | 2 | 21 | 10.24 | 5.12 | 29 | 2 | 22 | 11.00 | 6.65 |
12-week | 25 | 0 | 22 | 10.40 | 6.77 | 30 | 0 | 23 | 9.66 | 7.04 |
18-week | 25 | 0 | 21 | 8.96 | 5.62 | 30 | 0 | 21 | 10.23 | 7.01 |
PHQ-15 | ||||||||||
Baseline | 33 | 5 | 27 | 13.31 | 5.04 | 40 | 2 | 27 | 13.25 | 5.64 |
6-week | 29 | 2 | 23 | 11.86 | 5.18 | 29 | 1 | 23 | 11.90 | 5.63 |
12-week | 25 | 1 | 27 | 12.16 | 6.80 | 30 | 1 | 25 | 11.37 | 6.70 |
18-week | 25 | 0 | 23 | 10.79 | 6.48 | 30 | 1 | 25 | 11.38 | 6.16 |